Search and filter adverse-event reports.
1,929,324 reports(827 ms)
Reported to Dr. no concerns, monitoring for possible fever
A blister formed within 24 hrs at his vaccination site. Ruptured on it's own and is now healing
patient received the arexvy vaccine twice, once on 10/27/23 and once on 2/4/25
Patient stated that she has burning pain in her arm
Rash
Patient was given vaccine post temperature excursion prior to vaccine being properly cleared by vaccine coordinator with manufactures. Vaccines have successfully been cleared with manufacture and were cleared for patient use. This did not include MMR or Variva…
received the second dose of GARDASIL-9 a month late; No additional AE; This spontaneous report was received from an adult patient female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown d…
No side effects or symptoms reported; HCP called to report a patient received an expired dose of GARDASIL 9. It is unknown what dose in the series this vaccination is. no side effects or symptoms reported. Product has not undergone any temperature excursions,…
lingering cough; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of cough in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On…
suspected vaccination failure; Got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect…
Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown…
Suspected vaccination failure; husband vaccinated and has had shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccin…
Vaccination failure; diagnosed with disseminated herpes zoster/ severe HZ; This serious case was reported in a literature article and described the occurrence of vaccination failure in a 60-year-old female patient who received Herpes zoster (Zoster vaccine) fo…
Late 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 78-year-old female patient who received HAB (Twinrix) (batch number 4DS4N, expiry d…
Faint; Low grade fever; headache; nausea; diarrhea; cold sweat; Lightheadedness; This serious case was reported by a consumer via call center representative and described the occurrence of faint in a elderly female patient who received Herpes zoster (Shingrix)…
administered Flulaval when the patient was 4 months; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received Flu Se…
vial of antigen of Shingrix had been reconstituted using the Arexvy's diluent and potentially administered to a patient; vial of antigen of Shingrix had been reconstituted using the Arexvy's diluent and potentially administered to a patient; This non-serious c…
weakness; fever; trembling; This non-serious case was reported by a consumer via call center representative and described the occurrence of weakness in a 80-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Co-suspect products…
Inappropriate schedule of vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxi…
patient received 2 doses of Arexvy; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 68-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number…